Jared R Reese, MD | |
13060 Isle Dr, Baxter, MN 56425-8331 | |
(218) 828-2880 | |
Not Available |
Full Name | Jared R Reese |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 17 Years |
Location | 13060 Isle Dr, Baxter, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326212077 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 50950 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Essentia Health St Joseph's Medical Center | Brainerd, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Josephs Medical Center | 8224948443 | 215 |
News Archive
Scientists at KU Leuven, Belgium, have succeeded in growing three-dimensional cultures of the endometrium, the uterus' inner lining, in a dish.
MyFitnessPal, the leading free personal health and fitness system, today announced it has closed an $18 million Series A round of funding led by Kleiner Perkins Caufield & Byers with participation by Accel Partners. Both John Doerr and Andrew Braccia have also joined the company's board.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.
Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 5 days ago
Entity Name | St Josephs Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568415974 PECOS PAC ID: 8224948443 Enrollment ID: O20031119000468 |
News Archive
Scientists at KU Leuven, Belgium, have succeeded in growing three-dimensional cultures of the endometrium, the uterus' inner lining, in a dish.
MyFitnessPal, the leading free personal health and fitness system, today announced it has closed an $18 million Series A round of funding led by Kleiner Perkins Caufield & Byers with participation by Accel Partners. Both John Doerr and Andrew Braccia have also joined the company's board.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.
Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 5 days ago
Entity Name | Brainerd Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295801777 PECOS PAC ID: 0648270272 Enrollment ID: O20070105000140 |
News Archive
Scientists at KU Leuven, Belgium, have succeeded in growing three-dimensional cultures of the endometrium, the uterus' inner lining, in a dish.
MyFitnessPal, the leading free personal health and fitness system, today announced it has closed an $18 million Series A round of funding led by Kleiner Perkins Caufield & Byers with participation by Accel Partners. Both John Doerr and Andrew Braccia have also joined the company's board.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.
Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Jared R Reese, MD 523 N 3rd St, Brainerd, MN 56401-3054 Ph: (218) 829-2861 | Jared R Reese, MD 13060 Isle Dr, Baxter, MN 56425-8331 Ph: (218) 828-2880 |
News Archive
Scientists at KU Leuven, Belgium, have succeeded in growing three-dimensional cultures of the endometrium, the uterus' inner lining, in a dish.
MyFitnessPal, the leading free personal health and fitness system, today announced it has closed an $18 million Series A round of funding led by Kleiner Perkins Caufield & Byers with participation by Accel Partners. Both John Doerr and Andrew Braccia have also joined the company's board.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.
Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 5 days ago
Shiela Klemmetsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Essentia Health St. Joseph's-baxter Clinic, 13060 Isle Drive, Baxter, MN 56425 Phone: 218-828-2880 | |
Ammber Sahr, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7350 Clearwater Rd, Baxter, MN 56425 Phone: 218-454-5050 | |
Emily Maere Dunphy Day, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-2880 Fax: 218-454-5916 | |
Julie A Steinhauser, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13205 Isle Dr, Baxter, MN 56425 Phone: 218-454-7600 Fax: 218-546-4400 | |
Staci K Loken, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-2880 | |
Dr. Andrew Bader, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-2880 |